EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Ki67 dilemma: investigating prognostic cut-offs and reproducibility for automated Ki67 scoring in breast cancer

Emma Rewcastle, Ivar Skaland, Einar Gudlaugsson, Silja Kavlie Fykse, Jan P A Baak, Emiel A M Janssen

Breast Cancer Research and Treatment · 2024-08 · 207 (1) · 1-12

DOI: 10.1007/s10549-024-07352-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, online erschienen am 26.05.2024. Verfasst von Emma Rewcastle und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, Stavanger, Norway. emma.rewcastle@sus.no. Hauptthemen laut MEDLINE: Breast Neoplasms, Ki-67 Antigen, Biomarkers, Tumor. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helse Vest, University of Stavanger & Stavanger University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Quantification of Ki67 in breast cancer is a well-established prognostic and predictive marker, but inter-laboratory variability has hampered its clinical usefulness. This study compares the prognostic value and reproducibility of Ki67 scoring using four automated, digital image analysis (DIA) methods and two manual methods.

Methods

The study cohort consisted of 367 patients diagnosed between 1990 and 2004, with hormone receptor positive, HER2 negative, lymph node negative breast cancer. Manual scoring of Ki67 was performed using predefined criteria. DIA Ki67 scoring was performed using QuPath and Visiopharm® platforms. Reproducibility was assessed by the intraclass correlation coefficient (ICC). ROC curve survival analysis identified optimal cutoff values in addition to recommendations by the International Ki67 Working Group and Norwegian Guidelines. Kaplan–Meier curves, log-rank test and Cox regression analysis assessed the association between Ki67 scoring and distant metastasis (DM) free survival.

Results

The manual hotspot and global scoring methods showed good agreement when compared to their counterpart DIA methods (ICC > 0.780), and good to excellent agreement between different DIA hotspot scoring platforms (ICC 0.781–0.906). Different Ki67 cutoffs demonstrate significant DM-free survival (p < 0.05). DIA scoring had greater prognostic value for DM-free survival using a 14% cutoff (HR 3.054–4.077) than manual scoring (HR 2.012–2.056). The use of a single cutoff for all scoring methods affected the distribution of prediction outcomes (e.g. false positives and negatives).

Conclusion

This study demonstrates that DIA scoring of Ki67 is superior to manual methods, but further study is required to standardize automated, DIA scoring and definition of a clinical cut-off.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsKi-67 AntigenBiomarkers, TumorHumansFemalePrognosisMiddle AgedReproducibility of ResultsAgedAdultKaplan-Meier EstimateROC CurveAged, 80 and over

Stichwörter der Autor:innen

Artificial intelligenceBreast cancerDigital image analysisKi67Prognostic biomarkers

Substanzen

Ki-67 AntigenBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, Stavanger, Norway. emma.rewcastle@sus.no.
  • Department of Pathology, Stavanger University Hospital, Stavanger, Norway. emma.rewcastle@sus.no.
  • Department of Pathology, Stavanger University Hospital, Stavanger, Norway.
  • Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, Stavanger, Norway.

Förderung

  • Helse Vest
  • University of Stavanger & Stavanger University Hospital

Zitieren

APA

Rewcastle, E., Skaland, I., Gudlaugsson, E., Fykse, S. K., Baak, J. P. A., & Janssen, E. A. M. (2024). The Ki67 dilemma: investigating prognostic cut-offs and reproducibility for automated Ki67 scoring in breast cancer. Breast Cancer Research and Treatment, 207(1), 1-12. https://doi.org/10.1007/s10549-024-07352-4

Vancouver

Rewcastle E, Skaland I, Gudlaugsson E, Fykse SK, Baak JPA, Janssen EAM. The Ki67 dilemma: investigating prognostic cut-offs and reproducibility for automated Ki67 scoring in breast cancer. Breast Cancer Research and Treatment. 2024;207(1):1-12. doi:10.1007/s10549-024-07352-4

BibTeX
@article{Rewcastle2024,
  author = {Rewcastle, Emma and Skaland, Ivar and Gudlaugsson, Einar and Fykse, Silja Kavlie and Baak, Jan P A and Janssen, Emiel A M},
  title = {The Ki67 dilemma: investigating prognostic cut-offs and reproducibility for automated Ki67 scoring in breast cancer},
  journal = {Breast Cancer Research and Treatment},
  year = {2024},
  volume = {207},
  number = {1},
  pages = {1--12},
  doi = {10.1007/s10549-024-07352-4}
}
Kostenlos starten →